95 related articles for article (PubMed ID: 11870176)
1. Increasing single epirubicin doses in advanced soft tissue sarcomas.
Lopez M; Vici P; Di Lauro L; Carpano S
J Clin Oncol; 2002 Mar; 20(5):1329-34. PubMed ID: 11870176
[TBL] [Abstract][Full Text] [Related]
2. Ifosfamide plus epirubicin at escalating doses in the treatment of locally advanced and/or metastatic sarcomas.
Toma S; Palumbo R; Canavese G; Albanese E; Cantoni E; Barisone A; Reggiardo G; Rosso R; Santi L
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S222-7. PubMed ID: 8453703
[TBL] [Abstract][Full Text] [Related]
3. High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group.
Nielsen OS; Dombernowsky P; Mouridsen H; Crowther D; Verweij J; Buesa J; Steward W; Daugaard S; van Glabbeke M; Kirkpatrick A; Tursz T
Br J Cancer; 1998 Dec; 78(12):1634-9. PubMed ID: 9862576
[TBL] [Abstract][Full Text] [Related]
4. Ifosfamide and epirubicin combination in untreated sarcomas: two treatment schedules.
Serrone L; Zeuli M; Papaldo P; Nardoni C; Pacetti U; Cognetti F
Onkologie; 2001 Oct; 24(5):465-8. PubMed ID: 11694773
[TBL] [Abstract][Full Text] [Related]
5. Epirubicin and DTIC (EDIC) for advanced soft-tissue sarcomas.
Lopez M; Carpano S; Di Lauro L; Vici P; Conti EM
Oncology; 1991; 48(3):230-3. PubMed ID: 2023703
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of Preoperative Chemotherapy With or Without Radiation Therapy in Localized Soft Tissue Sarcomas of Limbs and Superficial Trunk in the Italian Sarcoma Group/Grupo Español de Investigación en Sarcomas Randomized Clinical Trial: Three Versus Five Cycles of Full-Dose Epirubicin Plus Ifosfamide.
Palassini E; Ferrari S; Verderio P; De Paoli A; Martin Broto J; Quagliuolo V; Comandone A; Sangalli C; Palmerini E; Lopez-Pousa A; De Sanctis R; Bottelli S; Libertini M; Picci P; Casali PG; Gronchi A
J Clin Oncol; 2015 Nov; 33(31):3628-34. PubMed ID: 26351345
[TBL] [Abstract][Full Text] [Related]
7. Epirubicin and ifosfamide in advanced soft tissue sarcomas.
Frustaci S; Foladore S; Buonadonna A; De Paoli A; Crivellari D; Carbone A; Sorio R; Morassut S; Monfardini S
Ann Oncol; 1993 Sep; 4(8):669-72. PubMed ID: 8240997
[TBL] [Abstract][Full Text] [Related]
8. Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy.
Huisman C; Biesma B; Postmus PE; Giaccone G; Schramel FM; Smit EF
Br J Cancer; 2001 Nov; 85(10):1456-61. PubMed ID: 11720428
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of epirubicin in advanced soft tissue sarcoma.
Chevallier B; Montcuquet P; Fachini T; Nguyen Bui B; Kerbrat P; Bastit P; Vo Van ML
Bull Cancer; 1990; 77(10):991-5. PubMed ID: 2249019
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of rapidly alternating epirubicin/dacarbazine and ifosfamide as first-line therapy for metastatic soft-tissue sarcoma in adults.
Harstrick A; Bokemeyer C; Schmoll HJ; Köhne-Wömpner CH; Knipp H; Schöffski P; Anagnou J; Wipperman B; Neumann S; Poliwoda H
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S217-21. PubMed ID: 8453702
[TBL] [Abstract][Full Text] [Related]
11. Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS).
Maurel J; Fra J; López-Pousa A; García del Muro X; Balañá C; Casado A; Martín J; Martínez-Trufero J; de las Peñas R; Buesa JM;
Cancer; 2004 Apr; 100(7):1498-506. PubMed ID: 15042685
[TBL] [Abstract][Full Text] [Related]
12. Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic offast cancer: the French experience.
Catimel G; Spielmann M; Dieras V; Tubiana-Hulin M; Bonneterre J; Pouillart P; Kayitalire L; Guastalla JP; Graffand N; Garet F; Dumortier A; Pellae-Cosset B
Semin Oncol; 1997 Feb; 24(1 Suppl 3):S8-12. PubMed ID: 9071333
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
Judson I; Verweij J; Gelderblom H; Hartmann JT; Schöffski P; Blay JY; Kerst JM; Sufliarsky J; Whelan J; Hohenberger P; Krarup-Hansen A; Alcindor T; Marreaud S; Litière S; Hermans C; Fisher C; Hogendoorn PC; dei Tos AP; van der Graaf WT;
Lancet Oncol; 2014 Apr; 15(4):415-23. PubMed ID: 24618336
[TBL] [Abstract][Full Text] [Related]
14. A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma.
Chawla SP; Goel S; Chow W; Braiteh F; Singh AS; Olson JEG; Osada A; Bobe I; Riedel RF
Clin Cancer Res; 2020 Aug; 26(16):4225-4232. PubMed ID: 32381487
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients.
Yovine A; Riofrio M; Blay JY; Brain E; Alexandre J; Kahatt C; Taamma A; Jimeno J; Martin C; Salhi Y; Cvitkovic E; Misset JL
J Clin Oncol; 2004 Mar; 22(5):890-9. PubMed ID: 14990645
[TBL] [Abstract][Full Text] [Related]
16. High-dose ifosfamide as second- or third-line chemotherapy in refractory bone and soft tissue sarcoma patients.
Lee SH; Chang MH; Baek KK; Han B; Lim T; Lee J; Park JO
Oncology; 2011; 80(3-4):257-61. PubMed ID: 21734417
[TBL] [Abstract][Full Text] [Related]
17. Phase I study of 3-weekly combination chemotherapy using epirubicin, oxaliplatin, and S-1 (EOS) in patients with previously untreated advanced gastric cancer.
Sym SJ; Hong J; Jung M; Park J; Cho EK; Lee WK; Chung M; Kim HS; Lee JH; Shin DB
Cancer Chemother Pharmacol; 2012 Aug; 70(2):277-84. PubMed ID: 22752217
[TBL] [Abstract][Full Text] [Related]
18. Dose-intensive chemotherapy with ifosfamide, epirubicin, and filgrastim for adult patients with metastatic or locally advanced soft tissue sarcoma: a phase II study.
Reichardt P; Tilgner J; Hohenberger P; Dörken B
J Clin Oncol; 1998 Apr; 16(4):1438-43. PubMed ID: 9552049
[TBL] [Abstract][Full Text] [Related]
19. Randomised study of high-dose epirubicin versus high-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma.
Jelić S; Kovcin V; Milanović N; Babović N; Kreacić M; Ristović Z; Vlajić M; Filipović-Ljesković I
Eur J Cancer; 1997 Feb; 33(2):220-5. PubMed ID: 9135492
[TBL] [Abstract][Full Text] [Related]
20. Epirubicin 150 mg/m2-cisplatin versus epirubicin 180 mg/m2-cisplatin for advanced soft tissue sarcoma.
Jelić S; Babović N; Kreacić M; Matković S; Milanović N; Gavrilović D; Tomasević Z
Int J Clin Pharmacol Res; 1999; 19(4):129-38. PubMed ID: 10939030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
